The alternating copolymerization of CO/epoxides is a useful means to incorporate high levels of carbon dioxide into polymers. The reaction is generally proposed to occur by bimetallic or bicomponent pathways. Here, the first indium catalysts are presented, which are proposed to operate by a distinct mononuclear pathway. The most active and selective catalysts are phosphasalen complexes, which feature ligands comprising two iminophosphoranes linked to sterically hindered ortho-phenolates. The catalysts are active at 1 bar pressure of carbon dioxide and are most effective without any cocatalyst. They show low-pressure activity (1 bar pressure) and yield polymer with high carbonate linkage selectivity (>99%) and isoselectivity ( P > 70%). Using these complexes, it is also possible to isolate and characterize key catalytic intermediates, including the propagating indium alkoxide and carbonate complexes that are rarely studied. The catalysts are mononuclear under polymerization conditions, and the key intermediates show different coordination geometries: the alkoxide complex is pentacoordinate, while the carbonate is hexacoordinate. Kinetic analyses reveal a first-order dependence on catalyst concentration and are zero-order in carbon dioxide pressure; these findings together with in situ spectroscopic studies underpin the mononuclear pathway. More generally, this research highlights the future opportunity for other homogeneous catalysts, featuring larger ionic radius metals and new ligands, to operate by mononuclear mechanisms.
Polylactide (PLA) is the leading bioderived polymer produced commercially by the metal‐catalyzed ring‐opening polymerization of lactide. Control over tacticity to produce stereoblock PLA, from rac‐lactide improves thermal properties but is an outstanding challenge. Here, phosphasalen indium catalysts feature high rates (30±3 m
−1 min−1, THF, 298 K), high control, low loadings (0.2 mol %), and isoselectivity (P
i=0.92, THF, 258 K). Furthermore, the phosphasalen indium catalysts do not require any chiral additives.
The ring-opening polymerization of macrolactones (C15–C23) is reported using an yttrium catalyst which shows high rates and conversions in the production of long-chain aliphatic polyesters.
'N-alkyl pyrrolidone ether podands as versatile alkali metal ion chelants.', Dalton transactions., 43 (8). pp.
3153-3161.Further information on publisher's website:Publisher's copyright statement:Additional information:
Use policyThe full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that:• a full bibliographic reference is made to the original source • a link is made to the metadata record in DRO • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders.Please consult the full DRO policy for further details.
The preparation and characterization of a series of 8-hydroxyquinoline ligands and their complexes with Ti(IV), Al(III) and Zn(II) centres is presented. The complexes are characterized using NMR spectroscopy, elemental analysis and, in some cases, by single crystal X-ray diffraction experiments. The complexes are compared as initiators for the ring-opening polymerization of racemic-lactide; all the complexes show moderate/good rates and high levels of polymerization control. In the case of the titanium or aluminium complexes, moderate iso-selectivity is observed (Pi = 0.75), whereas in the case of the zinc complexes, moderate hetero-selectivity is observed (Ps = 0.70).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.